Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000899243-22-031459

Options or other derivatives

  • Senior Vice President, Legal acquired 185,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lackey Melinda Senior Vice President, Legal 2022-09-15 Grant or award · Employee Stock Option (right to buy) +185,000 185,000 D
Loading xslF345X03/doc4.xml…